1
|
Silva-Fisher JM, Dang HX, White NM, Strand
MS, Krasnick BA, Rozycki EB, Jeffers GGL, Grossman JG, Highkin MK,
Tang C, et al: Long non-coding RNA RAMS11 promotes metastatic
colorectal cancer progression. Nat Commun. 11:21562020. View Article : Google Scholar : PubMed/NCBI
|
2
|
Jones WF, Ahnen DJ and Schroy PC III:
Improving on-time colorectal cancer screening through lead time
messaging. Cancer. 126:247–252. 2020. View Article : Google Scholar : PubMed/NCBI
|
3
|
Carvalho MR, Reis RL and Oliveira JM:
Dendrimer nanoparticles for colorectal cancer applications. J Mater
Chem B. 8:1128–38. 2020. View Article : Google Scholar : PubMed/NCBI
|
4
|
Azzam N, AlRuthia Y, Alharbi O, Aljebreen
A, Almadi M, Alarfaj M, Alsaleh K, Almasoud A, Alsharidah M,
Alseneidi S, et al: Predictors of survival among colorectal cancer
patients in a low incidence area. Cancer Manag Res. 12:451–459.
2020. View Article : Google Scholar : PubMed/NCBI
|
5
|
Nahm SH, Blinman P, Butler S, Tan SYC and
Vardy J: Factors associated with fear of cancer recurrence in
breast and colorectal cancer survivors: A cross-sectional study of
cancer survivors. Asia Pac J Clin Oncol. 17:222–229. 2021.
View Article : Google Scholar : PubMed/NCBI
|
6
|
He E, Lew JB, Egger S, Banks E, Ward RL,
Beral V and Canfell K: Factors associated with participation in
colorectal cancer screening in Australia: Results from the 45 and
up study cohort. Prev Med. 106:185–193. 2018. View Article : Google Scholar : PubMed/NCBI
|
7
|
Shen MH, Chen LP, Ho TF, Shih YY, Huang
CS, Chie WC and Huang CC: Validation of the Taiwan Chinese version
of the EORTC QLQ-CR29 to assess quality of life in colorectal
cancer patients. BMC Cancer. 18:3532018. View Article : Google Scholar : PubMed/NCBI
|
8
|
Zeng K, Chen X, Xu MU, Liu X, Hu X, Xu T,
Sun H, Pan Y, He B and Wang S: CircHIPK3 promotes colorectal cancer
growth and metastasis by sponging miR-7. Cell Death Dis. 9:4172018.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Crespo A, García-Suárez O, Fernández-Vega
I, Solis-Hernandez MP, García B, Castañón S and Quirós LM: Heparan
sulfate proteoglycans undergo differential expression alterations
in left sided colorectal cancer, depending on their metastatic
character. Bmc Cancer. 18:6872018. View Article : Google Scholar : PubMed/NCBI
|
10
|
Zhang J, Li XY, Hu P and Ding YS: lncRNA
NORAD contributes to colorectal cancer progression by inhibition of
miR-202-5p. Oncol Res. 26:1411–1418. 2018. View Article : Google Scholar : PubMed/NCBI
|
11
|
Liu Y, Chen X, Cheng R, Yang F, Yu M, Wang
C, Cui S, Hong Y, Liang H, Liu M, et al: The Jun/miR-22/HuR
regulatory axis contributes to tumourigenesis in colorectal cancer.
Mol Cancer. 17:112018. View Article : Google Scholar : PubMed/NCBI
|
12
|
Gao X, Wang C, Yu Y, Singh D, Yang L and
Zhou Z: Lateral lymph node dissection reduces local recurrence of
locally advanced lower rectal cancer in the absence of preoperative
neoadjuvant chemoradiotherapy: A systematic review and
meta-analysis. World J Surg Oncol. 18:3042020. View Article : Google Scholar : PubMed/NCBI
|
13
|
NHSN Patient Safety Component Manual, U.S,
. Centers for disease control and prevention, national healthcare
safety network. New York; USA: 2023
|
14
|
Hajibandeh S, Hajibandeh S, Matthews J,
Palmer L and Maw A: Meta-analysis of survival and functional
outcomes after total mesorectal excision with or without lateral
pelvic lymph node dissection in rectal cancer surgery. Surgery.
168:486–496. 2020. View Article : Google Scholar : PubMed/NCBI
|
15
|
Motoki Y, Sugimoto K, Sakisaka H, Nakano
K, Kan K, Nakaguchi K and Doi S: A case of laparoscopic surgery for
advanced rectal cancer with lateral lymph node metastasis resected
after neoadjuvant chemotherapy. Gan To Kagaku Ryoho. 45:2357–2359.
2018.(In Japanese). PubMed/NCBI
|
16
|
Zeng ZW, Zhang XW, Chen JJ, Huang L, Luo
SL and Kang L: Transanal lateral lymph node dissection surgery for
5 cases of mid-low rectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi.
22:781–785. 2019.(In Chinese). PubMed/NCBI
|
17
|
Aisu Y, Kato S, Kadokawa Y, Yasukawa D,
Kimura Y, Takamatsu Y, Kitano T and Hori T: Feasibility of extended
dissection of lateral pelvic lymph nodes during laparoscopic total
mesorectal excision in patients with locally advanced lower rectal
cancer: A single-center pilot study after neoadjuvant chemotherapy.
Med Sci Monit. 24:3966–3977. 2018. View Article : Google Scholar : PubMed/NCBI
|
18
|
Zhang X, Zhang Y, Wei M, Wang M, Yang X,
Deng X and Wang Z: Letter to the editor regarding ‘Does adding
lateral pelvic lymph node dissection to neoadjuvant chemotherapy
improve outcomes in low rectal cancer?’. Int J Colorectal Dis.
35:2139–2140. 2020. View Article : Google Scholar : PubMed/NCBI
|
19
|
Fujita S, Mizusawa J, Kanemitsu Y, Saito
N, Kinugasa Y, Kanemitsu Y, Ohue M, Fujii S, Shiozawa M, Yamaguchi
T, et al: Postoperative morbidity and mortality after mesorectal
excision with and without lateral lymph node dissection for
clinical stage II or stage III lower rectal cancer (JCOG0212):
Results from a multicentre, randomised controlled, non-inferiority
trial. Lancet Oncol. 13:616–621. 2012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Ozawa H, Kotake K, Hosaka M, Hirata A and
Sugihara K: Impact of lateral pelvic lymph node dissection on the
survival of patients with T3 and T4 low rectal cancer. World J
Surg. 40:1492–1499. 2016. View Article : Google Scholar : PubMed/NCBI
|
21
|
Ogura A, Akiyoshi T, Nagasaki T, Konishi
T, Fujimoto Y, Nagayama S, Fukunaga Y, Ueno M and Kuroyanagi H:
Feasibility of laparoscopic total mesorectal excision with extended
lateral pelvic lymph node dissection for advanced lower rectal
cancer after preoperative chemoradiotherapy. World J Surg.
41:868–875. 2017. View Article : Google Scholar : PubMed/NCBI
|
22
|
Akiyoshi T, Ueno M, Matsueda K, Konishi T,
Fujimoto Y, Nagayama S, Fukunaga Y, Unno T, Kano A, Kuroyanagi H,
et al: Selective lateral pelvic lymph node dissection in patients
with advanced low rectal cancer treated with preoperative
chemoradiotherapy based on pretreatment imaging. Ann Surg Oncol.
21:189–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
23
|
Lin ACH, Hakim A, Kellish AS, Singh P,
Wozniak M, Kwiatt M, Gaughan J and Hong YK: Inguinal lymph node
dissection does not improve overall survival in anal cancer nodal
disease. J Surg Res. 255:13–22. 2020. View Article : Google Scholar : PubMed/NCBI
|
24
|
Peacock O and George JC: The landmark
series: Management of lateral lymph nodes in locally advanced
rectal cancer. Ann Surg Oncol. 27:2723–2731. 2020. View Article : Google Scholar : PubMed/NCBI
|
25
|
Jayne D, Pigazzi A, Marshall H, Croft J,
Corrigan N, Copeland J, Quirke P, West N, Edlin R, Hulme C and
Brown J: Robotic-assisted surgery compared with laparoscopic
resection surgery for rectal cancer: The ROLARR RCT. Southampton
(UK): NIHR Journals Library; 2019, View
Article : Google Scholar
|
26
|
Xynos E, Tekkis P, Gouvas N, Vini L,
Chrysou E, Tzardi M, Vassiliou V, Boukovinas I, Agalianos C,
Androulakis N, et al: Clinical practice guidelines for the surgical
treatment of rectal cancer: A consensus statement of the hellenic
society of medical oncologists (HeSMO). Ann Gastroenterol.
29:103–126. 2016.PubMed/NCBI
|
27
|
Babaei M, Balavarca Y, Jansen L, Gondos A,
Lemmens V, Sjövall A, Brge Johannesen T, Moreau M, Gabriel L,
Gonçalves AF, et al: Minimally invasive colorectal cancer surgery
in Europe: Implementation and outcomes. Medicine (Baltimore).
95:e38122016. View Article : Google Scholar : PubMed/NCBI
|
28
|
Jeong SY: Surgical management of
colorectal cancer. J Korean Med Assoc. 53:569–581. 2010. View Article : Google Scholar
|
29
|
Valadão M, Cesar D, Véo CAR, Araújo RO, do
Espirito Santo GF, Oliveira de Souza R, Aguiar S Jr, Ribeiro R, de
Castro Ribeiro HS, de Souza Fernandes PH and Oliveira AF: Brazilian
society of surgical oncology: Guidelines for the surgical treatment
of mid-low rectal cancer. J Surg Oncol. 125:194–216. 2022.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Watanabe T, Muro K, Ajioka Y, Hashiguchi
Y, Ito Y, Saito Y, Hamaguchi T, Ishida H, Ishiguro M, Ishihara S,
et al: Japanese society for cancer of the colon and rectum (JSCCR)
guidelines 2016 for the treatment of colorectal cancer. Int J Clin
Oncol. 23:1–34. 2018. View Article : Google Scholar : PubMed/NCBI
|
31
|
Georgiou P, Tan E, Gouvas N, Antoniou A,
Brown G, Nicholls RJ and Tekkis P: Extended lymphadenectomy versus
conventional surgery for rectal cancer: A meta-analysis. Lancet
Oncol. 10:1053–1062. 2009. View Article : Google Scholar : PubMed/NCBI
|
32
|
Yokota M, Morikawa A, Nagahisa Y, Okabe M,
Kitagawa H and Kawamoto K: Combined use of curved scissors and the
soft coagulation system in robot-assisted lateral lymph node
dissection for rectal cancer-a video vignette. Colorectal Dis.
22:2359–2360. 2020. View Article : Google Scholar : PubMed/NCBI
|
33
|
Wong KY and Tan AM: Short term outcomes of
minimally invasive selective lateral pelvic lymph node dissection
for low rectal cancer. World J Gastrointest Surg. 12:178–189. 2020.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Sabra H, Alimoradi M, El-Helou E, Azaki R,
Khairallah M and Kfoury T: Perforated sigmoid colon cancer
presenting as an incarcerated inguinal hernia: A case report. Int J
Surg Case Rep. 72:108–111. 2020. View Article : Google Scholar : PubMed/NCBI
|
35
|
Hojo D, Murono K, Nozawa H, Kawai K, Hata
K, Tanaka T and Ishihara S: Utility of a three-dimensional printed
pelvic model for lateral pelvic lymph node dissection. Int J
Colorectal Dis. 35:905–910. 2020. View Article : Google Scholar : PubMed/NCBI
|
36
|
Tsukamoto S, Fujita S and Kanemitsu Y:
Author response to: Beyond T, N and M: Can lateral lymph node
dissection treat tumour deposits in advanced low rectal carcinoma?
Br J Surg. 107:e2912020. View Article : Google Scholar : PubMed/NCBI
|
37
|
Yang X, Yang S, Hu T, Gu C, Wei M, Deng X,
Wang Z and Zhou Z: What is the role of lateral lymph node
dissection in rectal cancer patients with clinically suspected
lateral lymph node metastasis after preoperative chemoradiotherapy?
A meta-analysis and systematic review. Cancer Med. 9:4477–4489.
2020. View Article : Google Scholar : PubMed/NCBI
|
38
|
Young R, Rajkomar A, Smart P and Warrier
S: Robotic-assisted complete mesocolic excision, central vascular
ligation and para-aortic lymph node dissection in multifocal
carcinoid: A case report and technical description. Int J Surg Case
Rep. 67:262–266. 2020. View Article : Google Scholar : PubMed/NCBI
|
39
|
Asari M, Aoyama T, Koumori K, Uchiyama M,
Maezawa Y, Sawazaki S, Numata M, Tamagawa H, Sato T, Osaragi T, et
al: The efficacy of D3 lymph node dissection in elderly patients
with colorectal cancer. Gan To Kagaku Ryoho. 47:259–261. 2020.(In
Japanese). PubMed/NCBI
|
40
|
van Gijn W, Marijnen CA, Nagtegaal ID,
Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, Påhlman L, Glimelius
B and van de Velde CJ; Dutch Colorectal Cancer Group, :
Preoperative radiotherapy combined with total mesorectal excision
for resectable rectal cancer: 12-Year follow-up of the multicentre,
randomised controlled TME trial. Lancet Oncol. 12:575–582. 2011.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Sauer R, Becker H, Hohenberger W, Rödel C,
Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF,
et al: Preoperative versus postoperative chemoradiotherapy for
rectal cancer. N Engl J Med. 351:1731–1740. 2004. View Article : Google Scholar : PubMed/NCBI
|
42
|
Takahashi T, Ueno M, Azekura K and Ohta H:
Lateral node dissection and total mesorectal excision for rectal
cancer. Dis Colon Rectum. 43 (10 Suppl):S59–S68. 2000. View Article : Google Scholar : PubMed/NCBI
|
43
|
Moriya Y, Sugihara K, Akasu T and Fujita
S: Importance of extended lymphadenectomy with lateral node
dissection for advanced lower rectal cancer. World J Surg.
21:728–732. 1997. View Article : Google Scholar : PubMed/NCBI
|
44
|
Ueno H, Mochizuki H, Hashiguchi Y,
Ishiguro M, Miyoshi M, Kajiwara Y, Sato T, Shimazaki H and Hase K:
Potential prognostic benefit of lateral pelvic node dissection for
rectal cancer located below the peritoneal reflection. Ann Surg.
245:80–87. 2007. View Article : Google Scholar : PubMed/NCBI
|